Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.75B |
| 2 |
MSLC
Morgan Stanley Pathway Large Cap Equity ETF
MSLC
|
+$2.07B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.75B |
| 4 |
Apple
AAPL
|
+$1.6B |
| 5 |
Tesla
TSLA
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.7B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.35B |
| 3 |
Strategy Inc
MSTR
|
+$1.3B |
| 4 |
Shopify
SHOP
|
+$1.14B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.03B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.55% |
| 2 | Financials | 11.55% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.08% |
| 5 | Communication Services | 6.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.27B
| $7.92M | ﹤0.01% |
211,852
+5,421
| +3% | +$212K |
|
|
PFC
3552
DELISTED
Premier Financial Corp. Common Stock
PFC
| $7.92M | ﹤0.01% |
309,590
-512
| -0.2% | -$13.4K |
|
3553
Rayonier Advanced Materials
RYAM
$610M
| $7.91M | ﹤0.01% |
958,446
+105,999
| +12% | +$892K |
|
3554
Amplitude
AMPL
$1.41B
| $7.91M | ﹤0.01% |
749,471
-799,430
| -52% | -$8M |
|
|
THR
3555
DELISTED
Thermon Group Holdings
THR
| $7.91M | ﹤0.01% |
274,771
+24,560
| +10% | +$723K |
|
|
NBH
3556
Neuberger Municipal Fund Inc
NBH
$304M
| $7.89M | ﹤0.01% |
762,205
-61,619
| -7% | -$665K |
|
3557
First Trust Dow Jones Select MicroCap Index Fund
FDM
$271M
| $7.87M | ﹤0.01% |
115,508
+5,518
| +5% | +$375K |
|
3558
ADC Therapeutics
ADCT
$144M
| $7.87M | ﹤0.01% |
3,956,172
+915,378
| +30% | +$2.4M |
|
|
ORKA
3559
Oruka Therapeutics
ORKA
$5.96B
| $7.87M | ﹤0.01% |
405,998
+337,865
| +496% | +$8.24M |
|
3560
Fidelity High Yield Factor ETF
FDHY
$579M
| $7.85M | ﹤0.01% |
162,761
-1,463
| -0.9% | -$71.4K |
|
3561
Phathom Pharmaceuticals
PHAT
$692M
| $7.85M | ﹤0.01% |
966,400
+526,910
| +120% | +$6.53M |
|
3562
Invesco NASDAQ Next Gen 100 ETF
QQQJ
$1.18B
| $7.85M | ﹤0.01% |
254,067
+24,144
| +11% | +$750K |
|
3563
Fidelity Limited Term Bond ETF
FLTB
$415M
| $7.84M | ﹤0.01% |
157,975
+79,597
| +102% | +$3.97M |
|
3564
FIGS
FIGS
$2.37B
| $7.84M | ﹤0.01% |
1,266,319
-2,785,791
| -69% | -$16.2M |
|
3565
abrdn Physical Palladium Shares ETF
PALL
$667M
| $7.82M | ﹤0.01% |
468,060
+69,105
| +17% | +$1.28M |
|
3566
Dimensional US Marketwide Value ETF
DFUV
$15.8B
| $7.81M | ﹤0.01% |
190,762
+63,914
| +50% | +$2.71M |
|
3567
NextNav
NN
$2.23B
| $7.81M | ﹤0.01% |
501,650
+66,342
| +15% | +$884K |
|
3568
Invesco BulletShares 2032 Municipal Bond ETF
BSMW
$214M
| $7.8M | ﹤0.01% |
311,013
+23,118
| +8% | +$585K |
|
3569
B2Gold
BTG
$6.64B
| $7.78M | ﹤0.01% |
3,188,884
-379,620
| -11% | -$1.11M |
|
3570
Cullinan Oncology
CGEM
$1.14B
| $7.77M | ﹤0.01% |
638,069
-35,303
| -5% | -$507K |
|
|
BSL
3571
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$170M
| $7.77M | ﹤0.01% |
541,782
+13,231
| +3% | +$190K |
|
3572
Conduent
CNDT
$264M
| $7.77M | ﹤0.01% |
1,922,265
+463,363
| +32% | +$1.84M |
|
3573
Vitesse Energy
VTS
$665M
| $7.75M | ﹤0.01% |
310,188
+1,844
| +0.6% | +$48.2K |
|
3574
Neumora Therapeutics
NMRA
$302M
| $7.75M | ﹤0.01% |
731,412
+377,721
| +107% | +$4.53M |
|
3575
OR Royalties Inc
OR
$6.2B
| $7.75M | ﹤0.01% |
427,931
+79,869
| +23% | +$1.55M |
|
Similar funds
Morgan Stanley's Q4 2024 Portfolio in Review
As of Q4 2024, Morgan Stanley held 8,265 positions worth $1.43T, up 3.5% from $1.38T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2024 filing shows 346 new, 3,539 increased, 3,177 reduced and 287 closed positions. Its largest new stake was Morgan Stanley Pathway Large Cap Equity ETF: 42,204,466 shares worth $2.03B. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $1.7B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2024 buy was Morgan Stanley Pathway Large Cap Equity ETF: 42,204,466 shares worth $2.03B.
- Morgan Stanley added most to NVIDIA in Q4 2024, an estimated $2.75B increase.
- Morgan Stanley's biggest Q4 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.7B.
- Morgan Stanley fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $259M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.43T portfolio in Q4 2024.
- Morgan Stanley opened 346 new positions and closed 287 in Q4 2024.
- Morgan Stanley's portfolio value rose 3.5% quarter-over-quarter to $1.43T.
Based on Morgan Stanley's 13F filing for Q4 2024, filed 14 Feb 2025.